Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

134 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice.
Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffé-Scrive M. Surwit RS, et al. Among authors: feinglos mn. Metabolism. 1995 May;44(5):645-51. doi: 10.1016/0026-0495(95)90123-x. Metabolism. 1995. PMID: 7752914
Therapy of insulin-independent diabetes mellitus: general considerations.
Lebovitz HE, Feinglos MN. Lebovitz HE, et al. Among authors: feinglos mn. Metabolism. 1980 May;29(5):474-81. doi: 10.1016/0026-0495(80)90173-0. Metabolism. 1980. PMID: 6990182
Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.
Lebovitz HE, Feinglos MN, Bucholtz HK, Lebovitz FL. Lebovitz HE, et al. Among authors: feinglos mn. J Clin Endocrinol Metab. 1977 Sep;45(3):601-4. doi: 10.1210/jcem-45-3-601. J Clin Endocrinol Metab. 1977. PMID: 903405
Sulfonylurea treatment of insulin-independent diabetes mellitus.
Feinglos MN, Lebovitz HE. Feinglos MN, et al. Metabolism. 1980 May;29(5):488-94. doi: 10.1016/0026-0495(80)90175-4. Metabolism. 1980. PMID: 6990184
Combination insulin-sulfonylurea therapy in type II diabetes mellitus.
Allen BT, Feinglos MN. Allen BT, et al. Among authors: feinglos mn. South Med J. 1987 Oct;80(10):1285-9. doi: 10.1097/00007611-198710000-00019. South Med J. 1987. PMID: 3310252 Review. No abstract available.
Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus.
Rebuffé-Scrive M, Surwit R, Feinglos M, Kuhn C, Rodin J. Rebuffé-Scrive M, et al. Metabolism. 1993 Nov;42(11):1405-9. doi: 10.1016/0026-0495(93)90190-y. Metabolism. 1993. PMID: 8231834
Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes.
Feinglos MN, Saad MF, Pi-Sunyer FX, An B, Santiago O; Liraglutide Dose-Response Study Group. Feinglos MN, et al. Diabet Med. 2005 Aug;22(8):1016-23. doi: 10.1111/j.1464-5491.2005.01567.x. Diabet Med. 2005. PMID: 16026367 Clinical Trial.
Oral agents in the management of type 2 diabetes mellitus.
Luna B, Feinglos MN. Luna B, et al. Among authors: feinglos mn. Am Fam Physician. 2001 May 1;63(9):1747-56. Am Fam Physician. 2001. PMID: 11352285 Review.
Depressed mood is a factor in glycemic control in type 1 diabetes.
Van Tilburg MA, McCaskill CC, Lane JD, Edwards CL, Bethel A, Feinglos MN, Surwit RS. Van Tilburg MA, et al. Among authors: feinglos mn. Psychosom Med. 2001 Jul-Aug;63(4):551-5. doi: 10.1097/00006842-200107000-00005. Psychosom Med. 2001. PMID: 11485108
Diet-induced type II diabetes in C57BL/6J mice.
Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Surwit RS, et al. Among authors: feinglos mn. Diabetes. 1988 Sep;37(9):1163-7. doi: 10.2337/diab.37.9.1163. Diabetes. 1988. PMID: 3044882
134 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback